<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
-----
PATHOGENESIS CORPORATION
- -------------------------------------------------------------------------------
(Name of Issuer)
SHARES OF COMMON STOCK, PAR VALUE $.001
- -------------------------------------------------------------------------------
(Title of Class of Securities)
70321E 10 4
------------------------------------------------------
(CUSIP Number)
J. Patrick Fitzsimmons
BAXTER INTERNATIONAL INC.
One Baxter Parkway
Deerfield, Illinois 60015
847.948.3781
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 21, 1995
------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the following box if a fee is being paid with the statement /X/. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 5 Pages
<PAGE>
COVER PAGE (Continued)
CUSIP No. 70321E 10 4
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above
Persons
BAXTER INTERNATIONAL INC...........36-0781620........................
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) .....................................................................
(b) X BAXTER HEALTHCARE CORPORATION IS THE RECORD HOLDER.................
- -------------------------------------------------------------------------------
(3) SEC Use Only.........................................................
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization...DELAWARE......................
- -------------------------------------------------------------------------------
(5) Sole Voting Power.....................................
-----------------------------------------------------------
Number of Shares (6) Shared Voting Power...........700,000.................
Beneficially Owned
by Each Reporting -----------------------------------------------------------
Person With
(7) Sole Dispositive Power................................
-----------------------------------------------------------
(8) Shared Dispositive Power......700,000.................
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
..................................................700,000.................
- -------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
..........................................................................
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)....6.42%...........
- -------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions)
.....................................................CO...................
..........................................................................
- -------------------------------------------------------------------------------
Page 2 of 5 Pages
<PAGE>
COVER PAGE (Continued)
CUSIP No. 70321E 10 4
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above
Persons
BAXTER HEALTHCARE CORPORATION......36-2604143........................
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) .....................................................................
(b) X BAXTER HEALTHCARE CORPORATION IS THE RECORD HOLDER.................
- -------------------------------------------------------------------------------
(3) SEC Use Only.........................................................
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization...DELAWARE......................
- -------------------------------------------------------------------------------
(5) Sole Voting Power.....................................
-----------------------------------------------------------
Number of Shares (6) Shared Voting Power...........700,000.................
Beneficially Owned
by Each Reporting -----------------------------------------------------------
Person With
(7) Sole Dispositive Power................................
-----------------------------------------------------------
(8) Shared Dispositive Power......700,000.................
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
..................................................700,000.................
- -------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
..........................................................................
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)....6.42%...........
- -------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions)
.....................................................CO...................
..........................................................................
- -------------------------------------------------------------------------------
Page 3 of 5 Pages
<PAGE>
ITEM 1. SECURITY AND ISSUER.
Shares of Common Shares, par value $.001
PathoGenesis Corporation
201 Elliott Avenue West
Seattle, Washington 98119
ITEM 2. IDENTITIES AND BACKGROUNDS.
(a) Baxter International Inc. Baxter Healthcare Corporation
a Delaware corporation, a Delaware corporation
is a public holding company for is the principal United States
health care supplies and services operating subsidiary of Baxter's
businesses. health care supplies and services
businesses.
(b) One Baxter Parkway One Baxter Parkway
Deerfield, Illinois 60015 Deerfield, Illinois 60015
(c) Delaware Delaware
(d) No. Not Applicable No. Not Applicable
(e) No. Not Applicable No. Not Applicable
ITEM 3. Not Applicable.
ITEM 4. OWNERSHIP.
In 1993, Baxter Healthcare Corporation, a Delaware corporation (the
"Corporation"), purchased 700,000 shares of PathoGenesis Corporation
("PathoGenesis") common stock. The Corporation is a subsidiary of Baxter
International Inc., a Delaware corporation. On November 21, 1995, PathoGenesis
completed an initial public offering. After these transactions, Baxter and
Corporation were the beneficial owners (as defined in Rule 13d-3 under the
Securities Exchange Act of 1934, as amended) of a total of 700,000 shares. This
total represents 6.42% of all outstanding shares of PathoGenesis common stock as
of December 31, 1995. These securities were acquired, and are held as part of
an ordinary course of business relationship between PathoGenesis and the Baxter
entities without any intent other than passive investment on the part of the
Baxter entities.
Page 4 of 5 Pages
<PAGE>
ITEM 5. Not Applicable.
ITEM 6. Not Applicable.
ITEM 7.
Baxter Healthcare Corporation, the record holder of these securities, is an
affiliate of Baxter International Inc. There are no other reportable items
under this caption with respect to these securities.
ITEM 10. CERTIFICATION.
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have the effect of changing
or influencing the control of the issuer of such securities and were not
acquired in connection with or as a participant in any transaction having such
purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Baxter International Inc.
By: /S/ A.G. Sieck
------------------------------
A.G. Sieck
Secretary
Baxter Healthcare Corporation
By: /S/ J.P. Fitzsimmons
------------------------------
J.P. Fitzsimmons
Assistant Secretary
Dated: February 14, 1996
Page 5 of 5 Pages
